Biologic Drugs in Drug Class: Interleukin-5 Antagonist
✉ Email this page to a colleague
Biologic Drugs in Drug Class: Interleukin-5 Antagonist
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | NUCALA | mepolizumab | For Injection | 125526 | 2015-11-04 | ⤷ Try a Trial | ⤷ Try a Trial |
Teva Respiratory, Llc | CINQAIR | reslizumab | Injection | 761033 | 2016-03-23 | ⤷ Try a Trial | ⤷ Try a Trial |
Teva Respiratory, Llc | CINQAIR | reslizumab | Injection | 761033 | 2016-03-23 | ⤷ Try a Trial | ⤷ Try a Trial |
Teva Respiratory, Llc | CINQAIR | reslizumab | Injection | 761033 | 2016-03-23 | ⤷ Try a Trial | ⤷ Try a Trial |
Glaxosmithkline Llc | NUCALA | mepolizumab | For Injection | 761122 | 2019-06-06 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |